PaoloFantiMD
Nephrology • San Antonio, TXAssociate Professor, Medicine, University of Texas Medical School, San Antonio
Are you Dr. Fanti?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 37 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4502 Medical Dr
San Antonio, TX 78229Phone+1 210-257-1400
Summary
- Dr. Paolo Fanti, MD is a nephrologist in San Antonio, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with Audie L. Murphy Memorial Veterans' Hospital and University Health / UT Health Science Center at San Antonio.
Education & Training
University of Kentucky College of MedicineFellowship, Nephrology, 1991 - 1992- University of Kentucky College of MedicineResidency, Internal Medicine, 1983 - 1991
University of BolognaClass of 1979
Certifications & Licensure
TX State Medical License 2007 - 2025
Clinical Trials
- Soy Protein in Early Diabetic Nephropathy Start of enrollment: 2001 Jul 01
- N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy Start of enrollment: 2009 Oct 01
- N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy Start of enrollment: 2011 Jan 01
Publications & Presentations
PubMed
- 3 citationsBalcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial.Carolyn S P Lam, Lars Køber, Koichiro Kuwahara, Lars H Lund, Patrick B Mark
European Journal of Heart Failure. 2024-08-01 - 7 citationsSpleen contributes significantly to increased circulating levels of fibroblast growth factor 23 in response to lipopolysaccharide-induced inflammation.Shweta Bansal, William E Friedrichs, Chakradhar Velagapudi, Denis Feliers, Khaled Khazim
Nephrology, Dialysis, Transplantation. 2017-06-01 - Spleen contributes significantly to increased circulating levels of fibroblast growth factor23 in response to lipopolysaccharide-induced inflammation.Shweta Bansal, William E Friedrichs, Chakradhar Velagapudi, Denis Feliers, Khaled Khazim
Nephrology, Dialysis, Transplantation. 2017-03-01
Grant Support
- Correction Of Glutathione Deficiency For Treatment Of Diabetic NephropathyVeterans Affairs2011–2012
- N-Acetylcysteine And Milk Thistle For Treatment Of Diabetic NephropathyNational Center For Complementary &Alternative Medicine2009–2011
- PK Of Silybin-Phosphatidylcholine Complex (SILIPHOS) In Diabetic NephropathyNational Center For Research Resources2006–2007
- Isoflavones:Acute Response In Chronic Renal FailureNational Center For Complementary &Alternative Medicine2001–2002
- Soy Protein Use In Early Diabetic NephropathyNational Center For Complementary &Alternative Medicine2000–2001
- Soybean &Urine Lithogenicity In Recurrent Calcium Oxalate NephropathyNational Center For Research Resources1999–2000
- Soybean &Urine Lithogenicity In Recurrent Calcium Oxalate NephrolithiasisNational Center For Research Resources1998
